BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25161024)

  • 21. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
    Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
    Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To use or not to use hydroxyethyl starch in intraoperative care: are we ready to answer the 'Gretchen question'?
    Heßler M; Arnemann PH; Ertmer C
    Curr Opin Anaesthesiol; 2015 Jun; 28(3):370-7. PubMed ID: 25887196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of resuscitation with human albumin 5%, hydroxyethyl starch 130/0.4 6%, or crystalloid on kidney damage in an ovine model of septic shock.
    Kampmeier TG; Arnemann PH; Hessler M; Bockbreder K; Wald A; Morelli A; Rehberg SW; Ertmer C
    Br J Anaesth; 2018 Sep; 121(3):581-587. PubMed ID: 30115256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human albumin solution for resuscitation and volume expansion in critically ill patients. The Albumin Reviewers.
    Bunn F; Lefebvre C; Li Wan Po A; Li L; Roberts I; Schierhout G
    Cochrane Database Syst Rev; 2000; (2):CD001208. PubMed ID: 10796756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study.
    ; Finfer S; Bellomo R; McEvoy S; Lo SK; Myburgh J; Neal B; Norton R
    BMJ; 2006 Nov; 333(7577):1044. PubMed ID: 17040925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in volume therapy in the intensive care unit?
    van Haren F; Zacharowski K
    Best Pract Res Clin Anaesthesiol; 2014 Sep; 28(3):275-83. PubMed ID: 25208962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Volume therapy: hydroxyethyl starch or saline? Hydroxyethyl starch in intensive care patients: there's an end of it!].
    Brunkhorst FM
    Dtsch Med Wochenschr; 2013 Jan; 138(3):66. PubMed ID: 23299339
    [No Abstract]   [Full Text] [Related]  

  • 28. Human albumin solution for resuscitation and volume expansion in critically ill patients.
    Alderson P; Bunn F; Lefebvre C; Li WP; Li L; Roberts I; Schierhout G;
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001208. PubMed ID: 15495011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy.
    Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
    Intensive Care Med; 2013 Apr; 39(4):558-68. PubMed ID: 23407978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous fluids in sepsis: what to use and what to avoid.
    Karakala N; Raghunathan K; Shaw AD
    Curr Opin Crit Care; 2013 Dec; 19(6):537-43. PubMed ID: 24240819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement.
    Cruickshanks M; Drummond GB; Paterson-Brown S; Powell AG
    BMJ; 2013 Jul; 347():f4651. PubMed ID: 23900815
    [No Abstract]   [Full Text] [Related]  

  • 32. Albumin is a blood product too - is it safe for all patients?
    Myburgh JA; Finfer S
    Crit Care Resusc; 2009 Mar; 11(1):67-70. PubMed ID: 19281447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human albumin solution for resuscitation and volume expansion in critically ill patients.
    Alderson P; Bunn F; Lefebvre C; Li WP; Li L; Roberts I; Schierhout G
    Cochrane Database Syst Rev; 2002; (1):CD001208. PubMed ID: 11869596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand?
    Groeneveld AB
    Crit Care; 2000; 4 Suppl 2(Suppl 2):S16-20. PubMed ID: 11255594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
    Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
    Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyethyl starch or saline in intensive care.
    Raghunathan K; Shaw A
    N Engl J Med; 2013 Feb; 368(8):774-5. PubMed ID: 23425177
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydroxyethyl starch or saline in intensive care.
    Guidet B
    N Engl J Med; 2013 Feb; 368(8):774. PubMed ID: 23425176
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydroxyethyl starch or saline in intensive care.
    Myburgh JA; Finfer S; Billot L;
    N Engl J Med; 2013 Feb; 368(8):775. PubMed ID: 23425175
    [No Abstract]   [Full Text] [Related]  

  • 39. Starch safety in resuscitation - when will we ever learn?
    Parrish A; Blockman M
    S Afr Med J; 2013 Apr; 103(6):365-7. PubMed ID: 23725952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The appropriate role of colloids in managing fluid imbalance: a critical review of recent meta-analytic findings.
    Webb AR
    Crit Care; 2000; 4 Suppl 2(Suppl 2):S26-32. PubMed ID: 11255596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.